BSEInsider Trading / SAST13 Oct 2026 · 13 Oct 2026, 10:28 am

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 12, 2026 for V C Nannapaneni

Natco Pharma Ltd · 524816

✦ AI SummaryPromoter Reclassif.

Natco Pharma Ltd has made a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicating a potential change in control or significant stake acquisition.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern5/10
Regulatory Risk6/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Natco Pharma Ltd - 524816 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.